Literature DB >> 4801689

[Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases].

H Held, R Eisert, H F von Oldershausen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4801689

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  7 in total

1.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

2.  Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  Disposition of valproic acid in patients with liver disease.

Authors:  U Klotz; T Rapp; W A Müller
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 4.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

Review 6.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

7.  [Decreased serum protein binding of glymidine in icteric liver disease and its partial correction with charcoal (author's transl].

Authors:  H Held
Journal:  Klin Wochenschr       Date:  1979-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.